Diaphorina citri psyllid: psy13847

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Mothers against decapentaplegic homolog 3	Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.	confident	P84024
Mothers against decapentaplegic homolog 3	Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.	confident	P84025
Mothers against decapentaplegic homolog 3	Transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinase. SMAD3 is a receptor-regulated SMAD (R-SMAD).	confident	P84023

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0001501 [BP]	skeletal system development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0051496 [BP]	positive regulation of stress fiber assembly	probable	GO:0051130, GO:0032231, GO:0032233, GO:0033043, GO:0051493, GO:0051495, GO:0032970, GO:0010638, GO:0051492, GO:0050794, GO:0044087, GO:0065007, GO:0032956, GO:0048518, GO:0008150, GO:0051128, GO:0050789, GO:0048522
GO:0007183 [BP]	SMAD protein complex assembly	probable	GO:0022607, GO:0070271, GO:0043933, GO:0007167, GO:0023052, GO:0007165, GO:0007166, GO:0034622, GO:0050789, GO:0044699, GO:0051716, GO:0071822, GO:0016043, GO:0065003, GO:0065007, GO:0071840, GO:0009987, GO:0006461, GO:0050794, GO:0044763, GO:0007154, GO:0043623, GO:0007178, GO:0044700, GO:0050896, GO:0044085, GO:0008150
GO:0002520 [BP]	immune system development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0002376, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0000979 [MF]	RNA polymerase II core promoter sequence-specific DNA binding	probable	GO:0044212, GO:0003676, GO:0043565, GO:0001067, GO:0000975, GO:0001012, GO:0000976, GO:0000977, GO:0001047, GO:0001046, GO:0003674, GO:0097159, GO:0003677, GO:1901363, GO:0005488
GO:0007492 [BP]	endoderm development	probable	GO:0032502, GO:0048856, GO:0008150, GO:0009888
GO:0031490 [MF]	chromatin DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:0003682, GO:1901363
GO:0005160 [MF]	transforming growth factor beta receptor binding	probable	GO:0005126, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0008285 [BP]	negative regulation of cell proliferation	probable	GO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0019049 [BP]	evasion or tolerance of host defenses by virus	probable	GO:0019048, GO:0052200, GO:0075136, GO:0000003, GO:0044419, GO:0044413, GO:0051832, GO:0044415, GO:0051834, GO:0009987, GO:0052173, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0051701, GO:0051707, GO:0051704, GO:0044703, GO:0009607, GO:0050896, GO:0016032, GO:0044403
GO:0001880 [BP]	Mullerian duct regression	probable	GO:0032502, GO:0007548, GO:0032501, GO:0000003, GO:0044707, GO:0022414, GO:0048856, GO:0060033, GO:0007275, GO:0044767, GO:0003006, GO:0008150, GO:0009653, GO:0046661, GO:0044699
GO:0043066 [BP]	negative regulation of apoptotic process	probable	GO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0010694 [BP]	positive regulation of alkaline phosphatase activity	probable	GO:0051336, GO:0019220, GO:0019222, GO:0051345, GO:0010921, GO:0010922, GO:0050790, GO:0031323, GO:0050789, GO:0051174, GO:0065007, GO:0044093, GO:0010692, GO:0008150, GO:0035303, GO:0050794, GO:0065009, GO:0043085
GO:0045667 [BP]	regulation of osteoblast differentiation	probable	GO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0051239, GO:0008150, GO:0030278, GO:0050789
GO:0016202 [BP]	regulation of striated muscle tissue development	probable	GO:1901861, GO:0050793, GO:0048634, GO:0008150, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0001102 [MF]	RNA polymerase II activating transcription factor binding	probable	GO:0001085, GO:0033613, GO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0042993 [BP]	positive regulation of transcription factor import into nucleus	probable	GO:0033157, GO:0032388, GO:0060341, GO:0051049, GO:0032386, GO:0051222, GO:0051223, GO:0050789, GO:0032880, GO:0065007, GO:0048518, GO:0070201, GO:0051050, GO:0090316, GO:0050794, GO:0008150, GO:0042307, GO:0042306, GO:0032879, GO:0042990, GO:1900180, GO:0046824, GO:0046822
GO:0005829 [CC]	cytosol	probable	GO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0006366 [BP]	transcription from RNA polymerase II promoter	probable	GO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0019438
GO:0007182 [BP]	common-partner SMAD protein phosphorylation	probable	GO:0016310, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0044699, GO:0044267, GO:0051716, GO:0044260, GO:0071704, GO:0065007, GO:0006468, GO:0044238, GO:0009987, GO:0006464, GO:0050794, GO:0043412, GO:0036211, GO:0044763, GO:0008152, GO:0007154, GO:0007178, GO:0044700, GO:0019538, GO:0050896, GO:0044237, GO:0043170, GO:0006796, GO:0006793, GO:0008150
GO:0009887 [BP]	organ morphogenesis	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0009880 [BP]	embryonic pattern specification	probable	GO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0007275, GO:0044699
GO:0017015 [BP]	regulation of transforming growth factor beta receptor signaling pathway	probable	GO:0090092, GO:0009966, GO:0048583, GO:0090287, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0009952 [BP]	anterior/posterior pattern specification	probable	GO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0005886 [CC]	plasma membrane	probable	GO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623
GO:0031625 [MF]	ubiquitin protein ligase binding	probable	GO:0003674, GO:0044389, GO:0005515, GO:0019899, GO:0005488
GO:0060290 [BP]	transdifferentiation	probable	GO:0032502, GO:0030154, GO:0048869, GO:0009987, GO:0044763, GO:0008150, GO:0044699
GO:0035556 [BP]	intracellular signal transduction	probable	GO:0044700, GO:0051716, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0001649 [BP]	osteoblast differentiation	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048869, GO:0030154, GO:0001503, GO:0044763, GO:0008150, GO:0009987, GO:0044699
GO:0061353 [BP]	BMP signaling pathway involved in Malpighian tubule cell chemotaxis	probable	GO:0032502, GO:0048856, GO:0061326, GO:0070887, GO:0019222, GO:0044700, GO:0031326, GO:0048619, GO:0060326, GO:0031323, GO:0006928, GO:0055123, GO:0030509, GO:0051674, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0048565, GO:0009653, GO:0072001, GO:0072002, GO:0006935, GO:0002009, GO:0051716, GO:0042330, GO:2000112, GO:0007275, GO:0019219, GO:0048513, GO:0065007, GO:0061352, GO:0048729, GO:0060562, GO:0048731, GO:0016477, GO:0010468, GO:0048598, GO:0040011, GO:0061333, GO:0060429, GO:0035239, GO:0061334, GO:0010556, GO:0060255, GO:0032501, GO:0009987, GO:0009889, GO:0009888, GO:0050794, GO:0044767, GO:0061525, GO:0044763, GO:0001655, GO:2001141, GO:0042221, GO:0035295, GO:0051179, GO:0080090, GO:0007178, GO:0007443, GO:0007442, GO:0044699, GO:0044707, GO:0009605, GO:0048870, GO:0050896, GO:0051252, GO:0050789, GO:0006355, GO:0007154, GO:0006357, GO:0008150, GO:0009790, GO:0048546, GO:0051171
GO:0003705 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	probable	GO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0051894 [BP]	positive regulation of focal adhesion assembly	probable	GO:0051130, GO:1901888, GO:1901890, GO:0010811, GO:0030155, GO:0001954, GO:0001952, GO:0090109, GO:0008150, GO:0044087, GO:0010810, GO:0048518, GO:0051893, GO:0065007, GO:0045785, GO:0051128, GO:0050789, GO:0050794, GO:0048522
GO:0048585 [BP]	negative regulation of response to stimulus	probable	GO:0008150, GO:0048519, GO:0065007, GO:0048583, GO:0050789
GO:0048468 [BP]	cell development	probable	GO:0032502, GO:0048856, GO:0048869, GO:0030154, GO:0044767, GO:0044763, GO:0008150, GO:0009987, GO:0044699
GO:0030501 [BP]	positive regulation of bone mineralization	probable	GO:0070169, GO:0045778, GO:0050793, GO:0051240, GO:0051094, GO:0070167, GO:0008150, GO:0048518, GO:2000026, GO:0051239, GO:0030500, GO:0065007, GO:0030278, GO:0050789
GO:0009967 [BP]	positive regulation of signal transduction	probable	GO:0009966, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0010720 [BP]	positive regulation of cell development	probable	GO:0051094, GO:0050793, GO:0060284, GO:0050794, GO:0045597, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0019902 [MF]	phosphatase binding	probable	GO:0003674, GO:0005515, GO:0019899, GO:0005488
GO:0007179 [BP]	transforming growth factor beta receptor signaling pathway	probable	GO:0007166, GO:0023052, GO:0007165, GO:0070887, GO:0007167, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0070848, GO:0071310, GO:0065007, GO:0071559, GO:0071495, GO:0009987, GO:0050794, GO:0042221, GO:0044763, GO:0007154, GO:0010033, GO:0007178, GO:0044700, GO:0071363, GO:0050896, GO:0071560, GO:0008150
GO:0003008 [BP]	system process	probable	GO:0032501, GO:0008150, GO:0044699, GO:0044707
GO:0030618 [MF]	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	probable	GO:0005057, GO:0005072, GO:0003674, GO:0004871, GO:0060089
GO:0050927 [BP]	positive regulation of positive chemotaxis	probable	GO:0040012, GO:0032103, GO:0040017, GO:0032101, GO:0048584, GO:0048583, GO:0050795, GO:0050789, GO:0008150, GO:0050926, GO:0050920, GO:0050921, GO:0048518, GO:0065007, GO:0048520
GO:0022603 [BP]	regulation of anatomical structure morphogenesis	probable	GO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0032444 [CC]	activin responsive factor complex	probable	GO:0031974, GO:0043229, GO:0043227, GO:0043226, GO:0005575, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0044428, GO:0005667, GO:0044424, GO:0044422
GO:0006810 [BP]	transport	probable	GO:0051234, GO:0008150, GO:0051179
GO:0001704 [BP]	formation of primary germ layer	probable	GO:0032502, GO:0048598, GO:0048856, GO:0044707, GO:0007369, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0048646, GO:0009653, GO:0007275, GO:0044699
GO:0005637 [CC]	nuclear inner membrane	probable	GO:0005575, GO:0016020, GO:0031090, GO:0005623, GO:0031965, GO:0005634, GO:0005635, GO:0019866, GO:0031967, GO:0005622, GO:0044446, GO:0043229, GO:0044428, GO:0012505, GO:0044424, GO:0044464, GO:0031975, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0071407 [BP]	cellular response to organic cyclic compound	probable	GO:0051716, GO:0050896, GO:0009987, GO:0008150, GO:0071310, GO:0044763, GO:0044699, GO:0070887, GO:0042221, GO:0010033, GO:0014070
GO:0006919 [BP]	activation of cysteine-type endopeptidase activity involved in apoptotic process	probable	GO:0019222, GO:2001056, GO:0007569, GO:0010941, GO:0042981, GO:0050789, GO:0043085, GO:0097202, GO:0051345, GO:2000116, GO:0043067, GO:0065007, GO:0044699, GO:0044093, GO:0043281, GO:0043280, GO:0065009, GO:0010259, GO:0009987, GO:0052547, GO:0052548, GO:0006915, GO:0050794, GO:0012501, GO:0044763, GO:0010950, GO:0010952, GO:0051336, GO:0050790, GO:0008150
GO:0071634 [BP]	regulation of transforming growth factor beta production	probable	GO:0008150, GO:0001817, GO:0065007, GO:0050789, GO:0051239
GO:0071141 [CC]	SMAD protein complex	probable	GO:0043234, GO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424
GO:0023019 [BP]	signal transduction involved in regulation of gene expression	probable	GO:0044700, GO:0051716, GO:0019222, GO:0008150, GO:0060255, GO:0050896, GO:0009987, GO:0050794, GO:0050789, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0010468, GO:0044699
GO:0070723 [BP]	response to cholesterol	probable	GO:1901700, GO:0033993, GO:0050896, GO:0008150, GO:0042221, GO:0036314, GO:0097305, GO:0010033, GO:0014070
GO:0010608 [BP]	posttranscriptional regulation of gene expression	probable	GO:0019222, GO:0060255, GO:0050789, GO:0008150, GO:0065007, GO:0010468
GO:0043130 [MF]	ubiquitin binding	probable	GO:0003674, GO:0032182, GO:0005488, GO:0005515
GO:0000987 [MF]	core promoter proximal region sequence-specific DNA binding	probable	GO:0044212, GO:0043565, GO:0097159, GO:0000975, GO:0001067, GO:0001159, GO:0000976, GO:0005488, GO:0003676, GO:0003677, GO:0003674, GO:1901363
GO:0065008 [BP]	regulation of biological quality	probable	GO:0008150, GO:0065007
GO:0000980 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding	probable	GO:0005488, GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001158, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363, GO:0035326
GO:0007507 [BP]	heart development	probable	GO:0032502, GO:0048513, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045165 [BP]	cell fate commitment	probable	GO:0032502, GO:0030154, GO:0048869, GO:0009987, GO:0044763, GO:0008150, GO:0044699
GO:0038092 [BP]	nodal signaling pathway	probable	GO:0044700, GO:0051716, GO:0032924, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0001105 [MF]	RNA polymerase II transcription coactivator activity	probable	GO:0001190, GO:0003713, GO:0003712, GO:0001104, GO:0001076, GO:0003674, GO:0000989, GO:0000988
GO:0045892 [BP]	negative regulation of transcription, DNA-dependent	probable	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0003690 [MF]	double-stranded DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0051098 [BP]	regulation of binding	probable	GO:0008150, GO:0065009, GO:0065007
GO:0030308 [BP]	negative regulation of cell growth	probable	GO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0045944 [BP]	positive regulation of transcription from RNA polymerase II promoter	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0070412 [MF]	R-SMAD binding	probable	GO:0046332, GO:0003674, GO:0005488, GO:0005515
GO:0070410 [MF]	co-SMAD binding	probable	GO:0046332, GO:0003674, GO:0005488, GO:0005515
GO:0008270 [MF]	zinc ion binding	probable	GO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction